Starting today, November 30, 2021, the following COVID-19
vaccines are accepted by the Government of Canada for international
travel in addition to the vaccines that have been recognized
earlier this year:
- Bharat Biotech (Covaxin, BBV152 A, B, C);
- Sinopharm (Beijing) BBIBP-CorV (Vero Cells);
- Sinovac (CoronaVac, PiCoVacc).
Previously recognized COVID-19 vaccines are:
- Pfizer-BioNTech (Comirnaty, tozinameran, BNT162b2);
- Moderna (Spikevax, mRNA-1273);
- AstraZeneca (Vaxzevria, COVISHIELD, ChAdOx1-S, AZD1222);
- Janssen/Johnson & Johnson (Ad26.COV2.S).
As advised by the Immigration, Refugees and Citizenship Canada
(IRCC), to qualify as a fully vaccinated traveller, the traveller
must have received at least 2 doses of an accepted vaccine or a mix
of 2 accepted vaccines, or 1 dose of the Janssen/Johnson &
Johnson vaccine. For someone to qualify as a fully vaccinated
traveller, the traveller must have received the second vaccine dose
(or the single
